▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2440185546875
▁pain 2.71484375
▁and 0.294921875
▁dem 7.14453125
oral 3.392578125
ization 0.1217041015625
. 1.046875
▁Chron 4.515625
ic 0.0032444000244140625
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.60546875
▁accompanied 2.984375
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.3955078125
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.341796875
▁person 0.69140625
’ 0.876953125
s 0.001071929931640625
▁ability 1.3916015625
▁to 0.036834716796875
▁receive 6.84375
▁joy 3.732421875
▁and 1.376953125
▁satisfaction 3.255859375
▁from 0.86572265625
▁life 0.7919921875
. 0.2283935546875
▁The 1.64453125
▁research 2.6875
▁investig 5.40625
ates 0.38720703125
▁the 0.38720703125
▁development 6.15625
▁of 0.1458740234375
▁de 3.841796875
pression 0.45849609375
▁and 1.3544921875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.6044921875
▁patients 1.48046875
▁receiving 5.83203125
▁ph 5.48046875
arma 3.224609375
ce 0.01218414306640625
ut 6.604194641113281e-05
ical 0.0064239501953125
▁op 4.64453125
io 0.09832763671875
ids 0.440185546875
▁and 2.4921875
▁medical 4.05859375
▁mar 1.75
iju 0.0010881423950195312
ana 4.851818084716797e-05
▁( 2.958984375
MM 1.2978515625
) 2.8984375
▁as 2.44140625
▁s 10.5
E 10.9765625
vere 8.28125
▁pain 0.8837890625
kill 4.31640625
ers 0.0106201171875
. 0.2802734375
▁It 3.267578125
▁comp 5.1328125
ares 0.00982666015625
▁the 0.59521484375
▁effic 4.3046875
acy 0.0021800994873046875
▁of 0.19287109375
▁pres 6.15234375
cri 1.9814453125
ptions 1.4091796875
▁and 1.916015625
▁exam 4.68359375
ines 0.012542724609375
▁the 0.474365234375
▁possibility 3.95703125
▁of 0.1278076171875
▁post 8.1640625
- 0.59765625
tre 1.9658203125
at 0.0016527175903320312
ment 0.005298614501953125
▁de 1.7060546875
pression 0.074951171875
. 1.353515625
<0x0A> 0.82373046875
There 4.6796875
▁is 1.19921875
▁currently 5.51953125
▁a 1.064453125
▁severe 5.015625
▁lack 1.9765625
▁of 0.01557159423828125
▁information 2.25390625
▁about 1.197265625
▁the 0.45751953125
▁effects 3.041015625
▁of 0.065673828125
▁op 3.052734375
i 3.423828125
ates 0.0250701904296875
. 3.31640625
▁They 4.49609375
▁man 12.7734375
a 4.47265625
Ge 2.4921875
▁pain 2.146484375
▁successfully 6.6484375
, 0.91357421875
▁but 0.2039794921875
▁the 2.484375
▁past 9.0625
▁few 2.2421875
▁dec 1.3271484375
ades 0.006195068359375
▁indicated 7.0703125
▁the 1.736328125
▁growing 3.810546875
▁concern 3.41796875
▁regarding 2.86328125
▁op 2.64453125
iate 1.2158203125
▁ab 1.6513671875
use 0.0168304443359375
▁in 3.876953125
▁forms 8.96875
▁of 0.26806640625
▁over 3.28125
d 0.10107421875
ose 0.328125
▁and 0.67333984375
▁add 0.73779296875
iction 0.0147552490234375
. 0.14208984375
▁A 4.04296875
▁more 4.6875
▁manage 7.94140625
able 0.0031909942626953125
▁and 2.099609375
▁sa 2.001953125
fer 0.00589752197265625
▁alternative 1.296875
▁might 5.234375
▁be 0.1192626953125
▁medical 1.65625
▁mar 0.1673583984375
iju 0.004364013671875
ana 0.0005917549133300781
. 0.94580078125
▁However 3.40625
, 0.00417327880859375
▁the 1.677734375
▁legal 4.05078125
▁status 1.2109375
▁and 3.14453125
▁novel 9.734375
ty 0.125
▁of 0.146240234375
▁this 2.32421875
▁drug 1.5009765625
▁do 4.3046875
▁not 0.0142364501953125
▁allow 0.68994140625
▁finding 7.015625
▁a 2.359375
▁large 2.55078125
▁number 0.79443359375
▁of 0.00370025634765625
▁studies 1.30859375
▁on 1.7705078125
▁its 0.81982421875
▁effect 2.3515625
iveness 0.1849365234375
. 0.6435546875
▁Specifically 8.9453125
, 0.056121826171875
▁it 2.63671875
▁concerns 5.01953125
▁the 0.830078125
▁emot 6.625
ional 0.023406982421875
▁condition 4.62890625
▁of 0.22216796875
▁patients 0.68603515625
▁experien 5.26953125
cing 0.00243377685546875
▁chron 0.84716796875
ic 0.0012273788452148438
▁pain 0.05596923828125
. 0.419677734375
▁This 2.9140625
▁research 1.830078125
▁paper 4.03125
▁a 1.89453125
ims 0.0006852149963378906
▁to 0.128662109375
▁analyze 3.36328125
▁levels 9.9453125
▁of 0.02325439453125
▁de 0.515625
pression 0.0239715576171875
▁and 0.1898193359375
▁anx 0.02496337890625
iety 0.0009131431579589844
▁among 0.7626953125
▁people 2.5
▁receiving 2.19140625
▁ther 6.515625
apy 0.078857421875
▁by 4.6328125
▁comparing 8.5703125
▁the 1.4892578125
▁effects 2.17578125
▁of 0.0274810791015625
▁ph 2.896484375
arma 0.031768798828125
ce 0.004276275634765625
ut 0.00035190582275390625
ical 0.00498199462890625
▁op 0.1446533203125
io 0.61865234375
ids 0.03228759765625
▁and 0.2491455078125
▁MM 0.49658203125
. 0.26171875
<0x0A> 0.473388671875
The 0.7470703125
▁study 1.708984375
▁was 2.23828125
▁conducted 0.60205078125
▁in 1.2509765625
▁the 1.4248046875
▁form 2.587890625
▁of 0.0031185150146484375
▁collection 11.6484375
▁and 0.669921875
▁analysis 0.392822265625
▁of 0.011962890625
▁statistical 3.7890625
▁data 0.1219482421875
. 0.890625
▁Part 5.19140625
icip 0.2147216796875
ants 0.07122802734375
▁were 0.68798828125
▁rec 3.537109375
ru 0.002216339111328125
ited 0.0005292892456054688
▁for 4.0859375
▁six 6.7578125
▁months 0.459228515625
▁at 3.861328125
▁two 2.623046875
▁major 3.966796875
▁pain 2.669921875
▁relief 4.0390625
▁cent 0.8154296875
ers 0.045562744140625
▁in 0.671875
▁Israel 5.37109375
. 0.32958984375
▁The 1.2265625
▁research 2.484375
ers 1.3828125
▁used 2.22265625
▁The 7.09375
▁De 2.95703125
pression 0.03045654296875
▁Module 6.69921875
▁of 0.7353515625
▁the 0.2369384765625
▁Pat 3.298828125
ient 0.01409912109375
▁Health 0.036346435546875
▁Question 0.020294189453125
naire 0.03448486328125
▁and 2.72265625
▁the 0.84814453125
▁General 1.1962890625
ized 0.5947265625
▁An 0.0074920654296875
x 0.0005669593811035156
iety 0.001041412353515625
▁Dis 0.17333984375
order 0.0240631103515625
▁Sc 1.470703125
ale 0.00328826904296875
▁to 0.91650390625
▁interview 7.578125
▁participants 2.7421875
, 4.3359375
▁evaluate 4.484375
▁their 0.54443359375
▁answers 4.1640625
, 0.341064453125
▁and 0.03564453125
▁conduct 4.984375
▁the 1.826171875
▁study 2.453125
. 0.09759521484375
▁To 4.8203125
▁specifically 9.984375
▁evaluate 3.3046875
▁and 5.14453125
▁compare 0.52978515625
▁the 0.393310546875
▁prob 9.921875
abilities 0.08306884765625
▁of 0.072998046875
▁de 0.8740234375
pression 0.032073974609375
▁or 4.3984375
▁anx 0.0478515625
iety 0.0006966590881347656
▁among 1.40234375
▁the 2.13671875
▁diverse 9.7578125
▁groups 0.79248046875
, 0.77490234375
▁the 0.439697265625
▁study 2.806640625
▁used 1.33984375
▁multiple 5.42578125
▁log 0.61962890625
istic 0.030609130859375
▁regression 0.26953125
▁analysis 1.328125
▁and 2.78125
▁chose 8.5625
▁medical 6.27734375
▁mar 0.0955810546875
iju 0.0022907257080078125
ana 0.0002307891845703125
▁as 0.54638671875
▁the 0.94140625
▁control 2.87109375
▁group 0.63232421875
. 0.263671875
<0x0A> 0.431640625
This 4.20703125
▁type 6.26171875
▁of 0.0026073455810546875
▁study 1.3740234375
▁is 1.392578125
▁the 3.73828125
▁most 1.298828125
▁reve 8.09375
aling 0.0017604827880859375
▁and 1.517578125
▁inclus 6.92578125
ive 0.0012187957763671875
, 3.11328125
▁as 1.2666015625
▁it 0.32373046875
▁contains 4.71484375
▁direct 5.99609375
▁responses 5.640625
▁from 0.56298828125
▁a 3.44921875
▁large 0.87451171875
▁number 0.459228515625
▁of 0.0033969879150390625
▁participants 0.98388671875
. 0.6201171875
▁All 5.37109375
▁tools 7.953125
▁in 5.8046875
▁the 0.8115234375
▁form 3.982421875
▁of 0.0175323486328125
▁question 0.65625
na 0.014404296875
ires 0.00011646747589111328
▁and 1.1962890625
▁scales 2.576171875
▁have 3.412109375
▁already 4.03125
▁been 0.393798828125
▁used 2.3203125
▁and 1.7451171875
▁proved 2.30859375
▁their 1.3291015625
▁effic 2.552734375
acy 0.005558013916015625
▁for 3.599609375
▁collect 4.1171875
ing 0.004085540771484375
▁analyt 7.171875
ical 0.0880126953125
▁data 0.1905517578125
. 0.365234375
▁It 3.376953125
▁helps 4.19921875
▁to 0.63671875
▁system 6.75390625
at 0.497314453125
ize 0.003208160400390625
▁and 1.2802734375
▁class 4.79296875
ify 0.00272369384765625
▁distinct 8.4375
▁kinds 6.4140625
▁of 0.016571044921875
▁information 2.06640625
▁for 4.01171875
▁subsequent 5.0078125
▁un 8.6171875
comp 4.46484375
licated 0.030029296875
▁services 12.4453125
. 0.55712890625
▁Thus 4.8359375
, 0.0055389404296875
▁research 4.4140625
ers 0.2413330078125
▁can 1.6494140625
▁compare 2.71484375
▁the 1.025390625
▁effects 2.9140625
▁of 0.103515625
▁medic 3.763671875
ations 0.65380859375
▁on 1.673828125
▁patients 2.013671875
▁of 4.16015625
▁diverse 3.060546875
▁age 2.0078125
▁groups 2.140625
, 0.7265625
▁background 3.767578125
s 0.118896484375
, 0.0181121826171875
▁physical 5.58203125
▁conditions 1.3017578125
, 0.037322998046875
▁emot 6.3828125
ional 0.02923583984375
▁states 1.3037109375
, 0.045196533203125
▁and 0.405517578125
▁so 2.498046875
▁on 0.1754150390625
. 0.0687255859375
<0x0A> 0.8125
The 0.71533203125
▁analysis 3.908203125
▁of 0.71533203125
▁any 9.6875
▁human 6.86328125
▁reaction 4.1015625
▁has 4.76953125
▁a 1.7353515625
▁high 3.1171875
▁potential 3.111328125
▁of 2.037109375
▁subject 2.935546875
iveness 3.53125
▁and 1.2841796875
▁bias 1.87890625
, 2.017578125
▁especially 2.375
▁regarding 3.880859375
▁people 4.94921875
▁in 3.849609375
▁severe 2.6953125
▁pain 0.5986328125
▁and 2.26171875
▁un 5.53515625
stable 0.93603515625
▁emot 0.630859375
ional 0.07696533203125
▁condition 2.484375
. 0.053619384765625
▁Perhaps 8.40625
▁some 5.1484375
▁patients 2.1640625
▁tend 4.765625
▁to 0.01007080078125
▁ex 2.037109375
agger 0.0093231201171875
ate 0.0020923614501953125
▁their 0.9521484375
▁de 3.25390625
press 1.806640625
ive 0.0767822265625
▁state 2.521484375
▁or 1.6337890625
▁vice 5.61328125
▁vers 0.027099609375
a 6.246566772460938e-05
, 1.0576171875
▁de 7.37890625
- 2.5078125
emph 0.354248046875
as 0.0030879974365234375
ize 0.07342529296875
▁serious 6.765625
▁difficulties 5.63671875
. 0.85498046875
▁Because 6.34375
▁the 2.736328125
▁survey 4.86328125
▁responses 6.89453125
▁were 1.4697265625
▁thoroughly 8.5859375
▁anonymous 3.005859375
, 0.26708984375
▁the 1.21484375
▁research 1.03125
ers 0.18408203125
▁were 2.478515625
▁unable 2.912109375
▁to 0.0013599395751953125
▁carefully 7.79296875
▁analyze 2.767578125
▁each 2.3984375
▁patient 2.572265625
’ 0.58203125
s 0.0011873245239257812
▁reaction 3.998046875
▁and 1.3232421875
▁compare 3.63671875
▁it 0.8203125
▁to 0.68017578125
▁the 0.9521484375
▁actual 4.4140625
▁states 7.734375
▁of 0.70458984375
▁condition 7.015625
. 0.347412109375
▁More 6.3828125
▁accurate 3.17578125
▁answers 4.3984375
▁could 1.8017578125
▁be 0.740234375
▁obtained 0.9921875
▁by 1.447265625
▁professional 5.94921875
▁psych 1.1875
olog 0.37841796875
ists 0.0028400421142578125
▁via 7.1015625
▁personal 2.548828125
▁communication 4.25
▁and 2.0078125
▁behavior 6.29296875
al 0.273193359375
▁analysis 2.072265625
. 0.244384765625
▁However 2.79296875
, 0.00043892860412597656
▁this 1.3994140625
▁method 2.33984375
▁of 2.6015625
▁research 1.8486328125
▁is 1.1513671875
▁way 5.73046875
▁more 0.86865234375
▁resource 4.62890625
- 0.2481689453125
int 1.392578125
ensive 0.0256195068359375
▁and 0.409912109375
▁energy 10.6484375
- 0.0645751953125
consum 0.346923828125
ing 0.0025196075439453125
. 0.701171875
<0x0A> 0.474609375
Part 5.8203125
icip 0.157470703125
ants 0.1278076171875
▁were 1.3271484375
▁rec 1.970703125
ru 0.0008025169372558594
ited 2.849102020263672e-05
▁for 1.73828125
▁six 0.33837890625
▁months 0.007091522216796875
▁at 0.379150390625
▁two 0.07464599609375
▁major 0.10638427734375
▁pain 0.0386962890625
▁relief 0.0218963623046875
▁cent 0.0122528076171875
ers 0.0014791488647460938
▁in 0.041290283203125
▁Israel 0.01117706298828125
. 0.1773681640625
▁All 4.4296875
▁patients 1.7509765625
▁experienced 4.18359375
▁chron 1.0859375
ic 0.0004379749298095703
▁pain 0.189208984375
▁for 2.638671875
▁at 0.63525390625
▁least 0.002655029296875
▁ 1.794921875
3 1.49609375
▁months 0.2447509765625
. 1.2294921875
▁The 1.39453125
▁study 1.638671875
▁included 1.6376953125
▁ 0.57080078125
8 3.01953125
9 2.486328125
0 2.869140625
▁participants 1.6044921875
, 1.4140625
▁of 2.712890625
▁which 0.42822265625
▁ 0.0975341796875
4 1.2998046875
7 2.578125
4 2.609375
▁( 2.97265625
5 0.09271240234375
9 4.90234375
%) 0.76708984375
▁were 0.78369140625
▁treated 3.12109375
▁sole 6.79296875
ly 0.0003333091735839844
▁with 0.289794921875
▁op 1.16796875
io 0.3603515625
ids 0.1453857421875
, 0.5400390625
▁ 0.69189453125
3 1.25
2 2.240234375
9 2.46484375
▁( 0.0455322265625
4 2.529296875
1 1.4599609375
%) 0.05877685546875
▁were 1.4599609375
▁treated 0.58154296875
▁with 0.357177734375
▁MM 0.69921875
, 0.369140625
▁and 0.10638427734375
▁ 0.2159423828125
7 2.0078125
7 2.4765625
▁( 0.108642578125
8 1.9033203125
. 0.921875
6 2.3984375
%) 0.07177734375
▁acquired 10.4140625
▁both 0.5986328125
▁( 5.015625
Fe 9.34375
ing 1.318359375
old 0.4189453125
▁et 1.0244140625
▁al 0.018035888671875
., 0.1461181640625
▁ 0.01457977294921875
2 0.006214141845703125
0 0.00026869773864746094
1 0.3994140625
7 1.708984375
). 0.04779052734375
▁The 1.2275390625
▁remaining 7.46875
▁ten 6.80078125
▁participants 1.3046875
▁who 4.83984375
▁did 2.20703125
▁not 0.00640106201171875
▁receive 2.212890625
▁ph 3.822265625
arma 0.087890625
ce 0.0011386871337890625
ut 1.3232231140136719e-05
ical 0.002643585205078125
▁op 1.3408203125
io 0.050140380859375
ids 0.0218353271484375
▁and 2.4375
▁medical 1.630859375
▁mar 0.035247802734375
iju 0.0006890296936035156
ana 0.00014340877532958984
▁were 0.4296875
▁with 6.84375
dra 0.05029296875
wn 0.0001468658447265625
▁from 0.2357177734375
▁the 0.1883544921875
▁analysis 2.28125
▁in 5.00390625
▁the 1.130859375
▁research 4.40625
. 1.0791015625
▁Therefore 5.12890625
, 0.00978851318359375
▁it 3.90625
▁is 1.322265625
▁not 2.955078125
▁possible 0.65966796875
▁to 0.0054473876953125
▁compreh 5.98046875
ens 0.1356201171875
ively 0.0160064697265625
▁compare 1.1943359375
▁patients 5.140625
▁taking 3.87890625
▁medic 4.23828125
ations 0.52734375
▁with 1.4453125
▁those 1.0244140625
▁who 0.74755859375
▁do 1.4501953125
▁not 0.0046234130859375
. 0.6103515625
<0x0A> 0.59033203125
The 0.8291015625
▁study 1.6455078125
▁conducted 4.265625
▁a 1.6982421875
▁correlation 6.52734375
▁type 9.2734375
▁of 0.1981201171875
▁research 0.93017578125
▁with 3.509765625
▁variable 8.5546875
▁measures 5.1640625
. 0.89404296875
▁It 1.44140625
▁evaluated 4.578125
▁the 0.5830078125
▁inter 6.08984375
dep 2.41015625
end 0.0005841255187988281
ence 0.00848388671875
▁of 0.59619140625
▁various 3.48046875
▁factors 0.86962890625
▁that 2.947265625
▁affected 4.09375
▁the 0.46630859375
▁physical 6.25390625
▁and 0.259765625
▁emot 0.414306640625
ional 0.00016295909881591797
▁condition 1.4833984375
▁of 0.0355224609375
▁patients 0.77001953125
▁experien 2.912109375
cing 9.298324584960938e-06
▁chron 0.2227783203125
ic 0.0003323554992675781
▁pain 0.01174163818359375
. 0.1270751953125
▁For 4.109375
▁example 1.11328125
, 0.0014295578002929688
▁the 1.0146484375
▁survey 5.59765625
▁showed 4.046875
▁that 0.44482421875
▁the 1.8564453125
▁ratio 6.76953125
▁of 0.089111328125
▁female 3.650390625
▁patients 0.98876953125
▁was 1.201171875
▁remark 8.0078125
ably 0.0004410743713378906
▁higher 0.180908203125
▁in 2.453125
▁the 0.46240234375
▁op 3.783203125
i 3.216796875
ates 0.01666259765625
▁group 0.2177734375
▁compared 2.4609375
▁to 0.039703369140625
▁the 0.59375
▁MM 0.163330078125
▁group 0.339111328125
. 0.5205078125
▁In 3.451171875
▁turn 3.83984375
, 0.001026153564453125
▁people 4.953125
▁on 4.7734375
▁op 2.9375
i 0.63134765625
ates 0.00443267822265625
▁were 0.8955078125
▁more 1.3623046875
▁likely 0.284423828125
▁to 0.022430419921875
▁report 2.828125
▁major 5.9765625
▁de 0.474609375
press 0.71923828125
ive 0.0027599334716796875
▁dis 0.94970703125
orders 1.564453125
. 1.6611328125
<0x0A> 2.162109375
The 0.8876953125
▁question 5.6015625
na 0.82958984375
ires 0.0003325939178466797
▁used 1.9248046875
▁different 7.80859375
▁variable 8.46875
▁measures 0.38671875
▁to 1.8388671875
▁collect 2.451171875
▁information 1.5732421875
. 1.306640625
▁For 1.6552734375
▁example 0.2763671875
, 0.0014467239379882812
▁it 4.19921875
▁included 1.9833984375
▁compreh 8.3828125
ensive 0.04620361328125
▁so 5.55078125
cio 0.0009822845458984375
- 0.289794921875
dem 0.12286376953125
ographic 0.06982421875
▁data 0.88037109375
: 4.90625
▁gender 2.072265625
, 0.044921875
▁age 0.255859375
, 0.0396728515625
▁country 4.1796875
, 2.732421875
▁type 4.39453125
▁of 0.05914306640625
▁residence 3.818359375
▁( 2.5625
urban 0.75
/ 1.3291015625
r 0.1541748046875
ural 0.001056671142578125
), 0.177978515625
▁years 6.27734375
▁of 0.1693115234375
▁education 0.693359375
, 0.08697509765625
▁and 1.3974609375
▁employ 2.5703125
ment 0.0020542144775390625
▁status 0.65576171875
. 0.1551513671875
▁Pat 4.6328125
ients 0.077392578125
▁were 1.1025390625
▁also 0.79345703125
▁asked 0.517578125
▁about 1.0166015625
▁their 0.6630859375
▁medical 2.486328125
▁history 0.56201171875
▁over 8.6484375
▁the 0.061431884765625
▁years 4.59375
▁and 1.6630859375
▁the 1.4619140625
▁current 2.966796875
▁presence 5.0
▁of 0.08001708984375
▁any 2.263671875
▁severe 3.77734375
▁dise 1.8876953125
ases 0.00012362003326416016
▁such 4.46875
▁as 0.0011911392211914062
▁heart 2.599609375
▁failure 1.62890625
, 0.31787109375
▁di 1.57421875
ab 0.0007901191711425781
etes 0.002391815185546875
, 0.06903076171875
▁ar 4.16015625
th 0.14306640625
rit 0.0296630859375
is 0.005275726318359375
, 0.025726318359375
▁and 1.1796875
▁so 0.7548828125
▁on 0.04736328125
. 0.0443115234375
▁The 1.708984375
▁third 6.78515625
▁measure 3.619140625
▁of 2.453125
▁the 0.60888671875
▁question 1.66015625
naire 0.3271484375
▁was 1.1044921875
▁indicated 10.625
▁by 1.12890625
▁information 6.80859375
▁on 2.009765625
▁any 5.671875
▁twelve 14.3671875
- 0.2010498046875
month 0.1434326171875
▁and 5.02734375
▁lifetime 0.654296875
▁drug 3.322265625
▁and 1.72265625
▁alco 0.14111328125
hol 0.00018548965454101562
▁consumption 4.47265625
. 0.4140625
▁In 3.630859375
▁addition 0.8984375
, 0.1907958984375
▁the 0.96337890625
▁record 10.2578125
▁included 1.2685546875
▁a 2.728515625
▁pain 4.50390625
▁measurement 5.0703125
▁scale 0.7880859375
▁from 4.296875
▁ 0.50390625
0 0.28466796875
▁to 0.2415771484375
▁ 0.00667572021484375
1 0.071044921875
0 0.034576416015625
▁to 3.1953125
▁evaluate 1.5390625
▁dis 6.0546875
com 0.11328125
fort 0.0012826919555664062
▁feelings 8.2109375
▁during 4.12109375
▁the 0.30810546875
▁last 1.1044921875
▁month 1.7177734375
. 0.21533203125
<0x0A> 0.4462890625
Am 6.078125
ong 0.006931304931640625
▁all 2.267578125
▁participants 2.048828125
▁in 3.67578125
▁the 0.170654296875
▁study 0.52392578125
, 0.040283203125
▁ 0.86474609375
4 1.8193359375
2 2.494140625
. 1.0810546875
2 2.23828125
% 0.05792236328125
▁suffered 3.69921875
▁from 0.04595947265625
▁de 1.6494140625
pression 0.2646484375
, 0.94287109375
▁and 1.1796875
▁ 0.12188720703125
3 1.4267578125
7 2.365234375
% 2.56640625
▁experienced 2.041015625
▁excess 6.9296875
ive 0.0262603759765625
▁anx 0.2152099609375
iety 0.0017604827880859375
. 0.363037109375
▁The 1.4248046875
▁pl 10.84375
ur 0.73095703125
ality 0.0010633468627929688
▁of 0.105712890625
▁de 2.42578125
press 1.2880859375
ive 0.035675048828125
▁dis 2.48828125
orders 0.071533203125
▁among 3.162109375
▁patients 1.025390625
▁in 2.77734375
▁the 0.30224609375
▁op 0.494384765625
i 0.376708984375
ates 0.0017757415771484375
, 9.1171875
▁medical 3.744140625
▁mar 0.02703857421875
iju 0.001079559326171875
ana 7.832050323486328e-05
, 0.178955078125
▁and 0.08831787109375
▁mixed 1.6279296875
▁OP 11.1640625
MM 4.125
▁groups 0.54296875
▁number 9.109375
ed 0.0173492431640625
▁ 0.1607666015625
5 1.638671875
7 2.6328125
. 0.50830078125
1 2.515625
%, 0.178466796875
▁ 0.0031490325927734375
2 2.115234375
2 2.638671875
. 0.10125732421875
3 2.26171875
%, 0.049285888671875
▁and 0.051605224609375
▁ 0.001697540283203125
5 1.9208984375
1 2.076171875
. 0.15576171875
4 1.8837890625
%, 0.160400390625
▁respectively 0.0233154296875
. 0.228759765625
▁The 1.2822265625
▁pl 3.861328125
ur 0.00997161865234375
ality 5.805492401123047e-05
▁of 0.023193359375
▁anx 0.431396484375
iety 0.0190887451171875
▁contained 10.84375
▁ 0.214599609375
4 1.1171875
8 2.353515625
. 0.17236328125
4 2.1875
% 2.08984375
▁among 2.5859375
▁OP 5.58984375
▁patients 6.26953125
, 0.270263671875
▁ 0.07421875
2 0.92919921875
1 2.48046875
. 0.113037109375
5 2.1171875
% 0.0240325927734375
▁among 0.447265625
▁MM 0.09576416015625
▁patients 0.35791015625
, 0.0166778564453125
▁and 0.01312255859375
▁ 0.023406982421875
3 1.3916015625
8 1.892578125
. 0.127685546875
7 2.208984375
% 0.0114898681640625
▁among 0.1923828125
▁OP 2.23828125
MM 0.122314453125
▁participants 3.095703125
. 0.2156982421875
▁Pat 5.08984375
ients 0.0179290771484375
▁who 1.94140625
▁took 2.2734375
▁strong 10.1484375
▁op 0.66259765625
i 0.7958984375
ates 0.00350189208984375
▁were 1.1611328125
▁t 10.09375
ended 1.1142578125
▁to 0.0070953369140625
▁place 9.8828125
▁their 2.03515625
▁pain 1.2373046875
▁on 1.92578125
▁a 0.58642578125
▁scale 1.8359375
▁of 0.381591796875
▁ 0.1036376953125
9 2.501953125
▁to 2.3125
▁ 0.01177215576171875
1 0.005794525146484375
0 0.00634002685546875
▁( 2.77734375
Fe 1.7900390625
ing 0.00348663330078125
old 0.0006136894226074219
▁et 0.012420654296875
▁al 0.0014848709106445312
., 0.0102386474609375
▁ 0.0016412734985351562
2 0.00018906593322753906
0 3.3974647521972656e-05
1 0.0017986297607421875
7 0.00624847412109375
). 0.01080322265625
▁They 4.48828125
▁were 1.6748046875
▁also 0.8974609375
▁an 9.59375
gu 4.6953125
ished 0.059967041015625
▁em 5.87890625
otion 0.0011110305786132812
ally 0.0007271766662597656
▁and 1.0654296875
▁react 7.5078125
ed 0.023345947265625
▁rad 9.0703125
ically 0.00194549560546875
▁neg 4.83203125
atively 0.0021457672119140625
▁to 0.1763916015625
▁almost 5.41015625
▁all 1.568359375
▁survey 3.796875
▁questions 0.2288818359375
. 0.3046875
▁Pat 3.783203125
ients 0.004459381103515625
▁who 1.251953125
▁took 1.6904296875
▁only 4.3515625
▁MM 0.329345703125
▁or 2.744140625
▁mixed 2.396484375
▁medic 1.306640625
ations 0.21337890625
▁course 13.796875
▁had 2.529296875
▁a 1.4072265625
▁significantly 2.83203125
▁more 3.087890625
▁stable 2.412109375
▁emot 0.814453125
ional 0.0011091232299804688
▁state 0.58740234375
▁and 1.0810546875
▁cop 6.63671875
ed 0.022613525390625
▁with 0.29638671875
▁pain 0.8193359375
▁more 1.8427734375
▁manage 6.71484375
able 1.677734375
. 0.27392578125
<0x0A> 0.260498046875
One 5.078125
▁of 0.2049560546875
▁the 0.0031566619873046875
▁major 2.681640625
▁limitations 2.4296875
▁is 2.884765625
▁the 0.484375
▁ins 4.6796875
u 0.0670166015625
fficient 0.049468994140625
ly 3.486328125
▁high 3.099609375
▁response 3.419921875
▁rate 0.09600830078125
, 2.724609375
▁ 4.5859375
5 1.654296875
7 2.841796875
% 2.283203125
▁instead 6.328125
▁of 0.0027618408203125
▁ 0.475830078125
7 1.87109375
0 0.435302734375
% 1.41015625
▁( 2.458984375
Fe 0.67138671875
ing 0.002231597900390625
old 0.00040602684020996094
▁et 0.009613037109375
▁al 0.000213623046875
., 0.007083892822265625
▁ 0.001338958740234375
2 0.00011432170867919922
0 0.00010120868682861328
1 0.00047969818115234375
7 0.00377655029296875
). 0.01104736328125
▁It 1.767578125
▁can 3.119140625
▁be 0.73291015625
▁fairly 8.3515625
▁explained 1.5400390625
▁by 0.1907958984375
▁the 0.27490234375
▁weak 7.44921875
▁focus 6.91796875
▁of 0.720703125
▁respond 5.7265625
ents 0.1094970703125
▁who 3.453125
▁have 3.91015625
▁overcome 8.2421875
▁severe 2.06640625
▁pain 0.55712890625
▁sens 7.5
ations 0.205810546875
▁and 0.88671875
▁de 4.76171875
press 0.77978515625
ive 0.047119140625
▁episodes 2.1484375
. 0.4912109375
▁It 2.818359375
▁is 0.7646484375
▁not 2.5625
▁clear 3.640625
▁how 1.9140625
▁to 3.4609375
▁use 5.27734375
▁these 2.787109375
▁statistics 3.8984375
, 3.046875
▁as 0.63623046875
▁they 1.900390625
▁still 5.171875
▁may 4.765625
▁be 1.2900390625
▁relevant 6.0078125
▁for 1.650390625
▁the 1.916015625
▁overall 4.7265625
▁analysis 2.69140625
. 0.91748046875
